Last $60.24 USD
Change Today +0.32 / 0.53%
Volume 576.0K
BMRN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for biomarin pharmaceutical inc (BMRN)

Year over year, BioMarin Pharmaceutical Inc. has been seen their bottom line shrink from a loss of $114.3M USD to an even larger loss of $176.4M USD despite an increase in revenues from $500.7M USD to $548.5M USD. An increase in the percentage of sales devoted to cost of goods sold from 78.70% to 82.14% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
Revenues376.3441.4500.7548.5
TOTAL REVENUES376.3441.4500.7548.5
Cost of Goods Sold217.6298.4394.0450.5
GROSS PROFIT158.7143.0106.798.0
Selling General & Admin Expenses, Total150.0175.4198.2235.4
Depreciation & Amortization, Total2.43.23.23.2
OTHER OPERATING EXPENSES, TOTAL152.4178.6201.4238.5
OPERATING INCOME6.3-35.7-94.7-140.6
Interest Expense-10.8-8.4-7.6-10.4
Interest and Investment Income4.12.92.63.1
NET INTEREST EXPENSE-6.7-5.5-5.1-7.4
Income (Loss) on Equity Investments-3.0-2.4-1.2-1.1
Other Non-Operating Income (Expenses)0.50.1-1.81.0
EBT, EXCLUDING UNUSUAL ITEMS-2.9-43.5-102.8-148.1
Merger & Restructuring Charges-1.8------
Gain (Loss) on Sale of Investments0.9------
Other Unusual Items, Total-17.7-0.1-15.5-28.4
Other Unusual Items-17.7-0.1-8.8-27.5
EBT, INCLUDING UNUSUAL ITEMS-21.5-43.6-118.3-176.5
Income Tax Expense-227.310.2-3.9-0.1
Earnings from Continuing Operations205.8-53.8-114.3-176.4
NET INCOME205.8-53.8-114.3-176.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS205.8-53.8-114.3-176.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS205.8-53.8-114.3-176.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $60.24 USD +0.32

BMRN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $48.71 USD +0.77
Amarin Corp PLC $1.62 USD +0.02
Dendreon Corp $2.27 USD -0.04
Jazz Pharmaceuticals Plc $154.70 USD -0.19
Spectrum Pharmaceuticals Inc $8.38 USD +0.12
View Industry Companies
 

Industry Analysis

BMRN

Industry Average

Valuation BMRN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.1x
Price/Book 6.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 12.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.